Clinical Trial Update: Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

This clinical trial update reports safety findings from a Phase 1 study of a peptide vaccine in patients with myelodysplastic syndrome, with the study status li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Myelodysplastic Syndrome (MDS) | Phase 1 | Status: COMPLETED